ACBI2 | m-entrepreneurship.com

Product Name :
ACBI2

Search keywords :
ACBI2

drugId :
null

Target Vo:
Probable global transcription activator SNF2L2

Target Vo Short Name :
SMARCA2

Moa_Name:
Probable global transcription activator SNF2L2 degraders

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
C.H. Boehringer Sohn Ag & Co. Kg

Active Company_Name :
C.H. Boehringer Sohn Ag & Co. Kg

Active Indication_Name:

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Litifilimab References
ZAP70 Rabbit mAb site
HDAC2 Antibody (YA742): HDAC2 Antibody (YA742) is a non-conjugated and Mouse origined monoclonal antibody about 55 kDa, targeting to HDAC2 (2D9). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat, Monkey.

Author: Betaine hydrochloride

Related Posts